Education
About Us
Working with TipRanks
Follow Us
Invion (AU:IVX)
ASX:IVX
IVX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.43
Previous CloseN/A
Volume36.17K
Average Volume (3M)175.80K
Market Cap
$11.13M
Enterprise ValueAU$7.22M
Total Cash (Recent Filing)$736.45K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.27
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding85,647,255
10 Day Avg. Volume405,038
30 Day Avg. Volume175,803
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue4.93
Enterprise Value/Gross Profit-35.66
Enterprise Value/Ebitda-1.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Invion News
IVX FAQ
What was Invion’s price range in the past 12 months?
Invion lowest share price was AU$0.08 and its highest was AU$0.43 in the past 12 months.
What is Invion’s market cap?
Invion’s market cap is $11.13M.
When is Invion’s upcoming earnings report date?
Invion’s upcoming earnings report date is Mar 04, 2026 which is in 184 days.
How were Invion’s earnings last quarter?
Invion released its earnings results on Aug 27, 2025. The company reported -AU$0.094 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.094.
Is Invion overvalued?
According to Wall Street analysts Invion’s price is currently Overvalued.
Does Invion pay dividends?
Invion does not currently pay dividends.
What is Invion’s EPS estimate?
Invion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion have?
Invion has 85,647,255 shares outstanding.
What happened to Invion’s price movement after its last earnings report?
Invion reported an EPS of -AU$0.094 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.043%.
Which hedge fund is a major shareholder of Invion?
Currently, no hedge funds are holding shares in AU:IVX
Invion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IVX Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.00%
12-Months-Change
Fundamentals
Return on Equity
-74.92%
Trailing 12-Months
Asset Growth
-39.74%
Trailing 12-Months
Company Description
Invion
Invion (IVX) is a biotechnology company focused on the research, development, and commercialization of Photodynamic Therapy (PDT) for the treatment of various cancers. Operating primarily in the healthcare and pharmaceutical sectors, Invion is dedicated to advancing its novel technologies to offer innovative treatment solutions that can improve patient outcomes. The company's core products include its proprietary PDT compounds and related systems that leverage light-activated processes to target and destroy cancer cells.
Technical Analysis
Elixinol Wellness
―
Cann Group
―
Ecofibre
―
Epsilon Healthcare Limited
―
Bod Australia Ltd
―
Ownership Overview
7.14% Insiders
―
Mutual Funds
― Other Institutional Investors
92.86% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---